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Abstract
 
We have analyzed the role of histamine in the angiogenesis of the granulation tissue in histidine
 
decarboxylase–deficient (HDC
 
 
 
/
 
 
 
) mice, mast cell–deficient mice (WBB6F1-
 
W/W
 
V
 
), and
their corresponding wild-type mice (HDC
 
 
 
/
 
 
 
 and WBB6F
 
1
 
 
 
/
 
 
 
). In HDC
 
 
 
/
 
 
 
 mice, subcuta-
neous implantation of a cotton thread in the dorsum induced granulation tissue formation with
angiogenesis, while the topical injection of antivascular endothelial growth factor (VEGF) IgG
strongly suppressed them. In HDC
 
 
 
/
 
 
 
 mice which showed lower VEGF levels in the granula-
 
tion tissue, there was notably less angiogenesis and granulation tissue formation than in HDC
 
 
 
/
 
 
 
mice. The topical injection of histamine or the H
 
2
 
 agonist dimaprit rescued the defective an-
giogenesis and granulation tissue formation in HDC
 
 
 
/
 
 
 
 mice. There was no significant differ-
ence in the granulation tissue formation and angiogenesis between WBB6F1-
 
W/W
 
V
 
 and
WBB6F1
 
 
 
/
 
 
 
 mice. In addition, macrophages in the granulation tissue were found to express
HDC. Our findings indicate that histamine derived from nonmast cells plays a significant role
in the angiogenesis of the inflammatory granulation tissue.
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Introduction
 
The progress of chronic and proliferative inflammation de-
pends on angiogenesis (1). It is required not only for the
maintenance of tissue perfusion, but also to allow an in-
crease in the cellular traffic required for chronicity (2).
Therefore, the inhibition of angiogenesis would be a valid
target for drug development in chronic inflammatory dis-
eases such as rheumatoid arthritis (3), atherosclerosis (4), di-
abetic retinopathy (5), psoriasis (6), wound healing (7), and
chronic airway inflammation (8), as well as for antineoplas-
tic therapy and Kaposi’s sarcoma (9).
 
Vascular endothelial growth factor (VEGF)
 
*
 
 is a potent
inducer of angiogenesis (10). Hypoxia conditions induce
VEGF production, in which the transcription factor hy-
poxia–inducible factor-1 is activated (11). In addition,
PGE2 induces VEGF production via the cAMP-protein ki-
nase A pathway (12) and enhances angiogenesis in carragee-
nin-induced proliferative granulation tissue (13) and in cul-
tures of human umbilical vein endothelial cells treated with
the conditioned medium of colon cancer cells (14). How-
ever, we have suggested that mediators other than PGE
 
2
 
participate in VEGF production by the inflammatory gran-
ulation tissue, because the cyclooxygenase inhibitors in-
domethacin and NS-398 only partially suppressed the
VEGF production (13). Zauberman et al. (15) first showed
that histamine is an angiogenic in rabbit cornea. In addi-
tion, histamine was found to be produced in rapidly grow-
ing granulation tissue (16, 17) and was thought to promote
neoplastic growth and angiogenesis (18–21). It is also re-
ported that endogenous histamine has dual roles in angio-
genesis in rats (22). Although these findings indicate that
histamine might have the ability to induce angiogenesis,
convincing proof that endogenous histamine upregulates
angiogenesis in the granulation tissue is still lacking. Re-
cently, we found that in a carrageenin-induced air pouch-
type inflammation model in rats, the angiogenesis that occurs
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during the formation of granulation tissue was inhibited by
treatment with cimetidine through the suppression of
VEGF protein induction (23). In addition, in vitro experi-
ments revealed that histamine induces VEGF production in
the granulation tissue (23). However, the specific role of
histamine in angiogenesis and the source of histamine in
the proliferative inflammatory tissue remain to be eluci-
dated.
In this study, we analyzed the role of endogenous hista-
mine in the angiogenesis of the cotton thread-induced
granulation tissue using histidine decarboxylase-deficient
mice (HDC
 
 
 
/
 
 
 
), mast cell–deficient mice (WBB6F1-
 
W/
W
 
V
 
), and their corresponding wild-type mice (HDC
 
 
 
/
 
 
 
and WBB6F
 
1
 
 
 
/
 
 
 
).
 
Materials and Methods
 
Animals and Drugs.
 
HDC-deficient 129 inbred mice (25–28 g)
were generated by a gene targeting method as described previ-
ously (24). WBB6F1
 
 
 
/
 
 
 
 and WBB6F1-
 
W/W
 
V
 
 mice (25–28 g)
were purchased from Japan SLC, Inc. Drugs used were pyril-
amine maleate, cimetidine (Sigma-Aldrich), thioperamide (a gift
from J.C. Schwartz, Unite de Neurobiologie et Pharmacologie
Moleculaire [U.109] de l’INSERM, Paris, France), dimaprit (Re-
search Biochemicals International), histamine (Sigma-Aldrich),
goat anti-VEGF IgG, and control goat IgG (R&D Systems).
 
Induction of Cotton Thread–induced Granulation Tissue in Mice.
 
A cotton thread (model no. 8; Araiwa Co.) was washed over-
night with ethyl acetate, and dried at room temperature before
being cut into 1 cm in length (7 mg weight) and sterilized by dry
heat at 160
 
 
 
C for 2 h. Male 129 inbred mice (25–28 g) were
anesthetized and a cotton thread (1 cm, 7 mg) was implanted
subcutaneously in the dorsum using a 13-G implant needle (Nat-
sume Co.) according to the procedure described elsewhere (25)
with a slight modification. The mice were treated in accordance
with procedures approved by the Animal Ethics Committee of
the Graduate School of Pharmaceutical Sciences, Tohoku Uni-
versity, Sendai, Japan.
 
Determination of Granulation Tissue Weight and Assessment of An-
giogenesis in the Granulation Tissue.
 
Mice were anesthetized and
killed by dislocation of the cervical spine at the indicated days af-
ter cotton thread implantation. The granulation tissue formed was
dissected together with the cotton thread and weighed. Angio-
genesis was assessed by taking photographs of the vascular net-
work formation around the cotton thread and the subcutaneous
tissue beneath the cotton thread. The dissected granulation tissue
together with the cotton thread was washed in PBS, pH 7.4, and
cut into small pieces with scissors before being homogenized in
20 vol of 0.5 mM sodium hydroxide using a Vir-Tis 45 homoge-
nizer (Virtis Company) for 4 min at the scale 40 on an ice bed.
The tissue homogenate was centrifuged at 10,000 
 
g
 
 and 4
 
 
 
C for
30 min. An aliquot (200 
 
 
 
l) of the supernatant was centrifuged
again at 14,000 
 
g
 
 and 4
 
 
 
C for 30 min. The hemoglobin concen-
tration in the supernatant was then determined spectrophotomet-
rically by measuring the absorbance at 540 nm using a hemoglo-
bin assay kit (Hemoglobin B Test Wako; Wako Pure Chemical
Ind.). The amount of hemoglobin in the granulation tissue was
expressed as 
 
 
 
g hemoglobin/mg wet tissue.
 
Western Blot Analysis of VEGF Proteins.
 
After protein levels
in the supernatant of the homogenate of the granulation tissue
were determined (26), aliquots containing 0.56 
 
 
 
g of protein
were separated by electrophoresis on a 12% (wt/vol) SDS-poly-
acrylamide gel and then transferred onto a nitrocellulose mem-
brane (Schleicher and Schuell, Inc.). The membrane was first in-
cubated with mouse monoclonal anti-VEGF (1:200; Santa Cruz
Biotechnology, Inc.) at 4
 
 
 
C for 12 h, followed by biotinylated
anti–mouse IgG (1:2,000; Vector Laboratories) at 4
 
 
 
C for 3 h,
and finally in the avidin-biotin-peroxidase complex (Vector Lab-
oratories) at room temperature for 30 min. The reaction product
was visualized with an ECL kit (ECL System; Amersham Phar-
macia Biotech).
Figure 1. Granulation tissue formation by implantation of a cotton
thread. A cotton thread (1 cm, 7 mg) was implanted subcutaneously in
the dorsum of each mouse. The mice were killed 1, 3, 5, 7, and 14 d after
cotton thread implantation. (A) The granulation tissue weight. (B) He-
moglobin levels in the granulation tissue. (C) VEGF protein levels in the
granulation tissue. VEGF protein levels in the granulation tissue were de-
termined by immunoblotting and analyzed densitometrically. Represen-
tative immunoblots from two mice in each group are shown at the top of
C. The mean VEGF protein level in the granulation tissue 1 d after cotton
thread implantation in the control group is set to 1.0. Values are the
means from five to six mice with SEM shown by vertical bars. *P   0.05;
**P   0.01; and ***P   0.001 compared with values at 1 d after cotton
thread implantation. 
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Determination of VEGF Proteins.
 
Concentrations of VEGF
proteins in the supernatant of the homogenate of the granulation
tissue were determined using a commercially available ELISA kit
(R&D Systems). In brief, 50 
 
 
 
l of the assay diluent and 50 
 
 
 
l of
the diluted sample solution were incubated at room temperature
in the dark for 2 h in each well of 96-well microplates precoated
with polyclonal antibody specific to mouse VEGF. After wash-
ing, 100 
 
 
 
l solution of an antibody against mouse VEGF conju-
gated to horseradish peroxidase was added to each well and incu-
bated at room temperature in the dark for 2 h.
After incubation, the plates were washed again and 100 
 
 
 
l of
the substrate solution containing stabilized hydrogen peroxide
and tetramethylbenzidine was added to each well and incubated
for 30 min at room temperature in the dark. Thereafter, 100 
 
 
 
l
of the stop solution was added to each well and the absorbance at
450 nm was determined. The intensity of the colored product is
proportional to the concentration of mouse VEGF present in the
original samples.
Coefficient of variations in intraassay and interassay precision
of this assay kit is 4.3–8.2% and 5.7–8.4%, respectively. Total
protein contents in the supernatant of the homogenate of the
granulation tissue were determined (26), and the contents of
VEGF proteins were expressed as pg VEGF per 
 
 
 
g total protein.
 
Measurement of HDC Activity in the Tissue around the Cotton
Thread.
 
A piece of the tissue, 2 cm in diameter surrounding the
implanted cotton thread including the skin, cutaneous muscle
layer, subcutaneous tissues, and the granulation tissue, was dis-
sected together with the cotton thread, 0, 1, 3, and 5 d after cot-
ton thread implantation. The dissected tissue including the cot-
ton thread was homogenized in 20 vol of an HDC reaction
buffer (0.1 M potassium-phosphate buffer, pH 6.8, 0.2 mM
 
dithiothreitol, 0.01 mM pyridoxal 5
 
 
 
-phosphate, 2 
 
 
 
g/ml leu-
peptin, 2 
 
 
 
g/ml pepstatin, and 1% [vol/vol] polyethylene glycol,
MW 300) for 4 min at the scale 40 on an ice bed using a Vir-Tis
45 homogenizer. The tissue homogenate was centrifuged at
10,000 
 
g
 
 and 4
 
 
 
C for 30 min. The supernatant of the homoge-
nate was then dialyzed overnight against the same buffer to re-
move endogenous histamine. Next, 1 ml of the dialyzed super-
natant was preincubated at 37
 
 
 
C for 10 min. The sample was
then incubated with or without 
 
l
 
-histidine at 37
 
 
 
C for 3 h. The
reaction was stopped by adding perchloric acid. Final concentra-
tions of 
 
l
 
-histidine and perchloric acid in the reaction mixture
were 0.25 mM and 0.4 N, respectively. After centrifugation at
220 
 
g
 
 and 4
 
 
 
C for 3 min, the supernatant was collected, and the
amount of histamine in the supernatant determined fluorometri-
cally (27). Protein levels in the dialyzed supernatant were deter-
mined (26), and HDC activity was expressed as the amount of
histamine formed per min per mg protein.
 
Immunostaining for HDC.
 
After dissection, the granulation tis-
sue together with the cotton thread were fixed in PBS containing
10% (vol/vol) formalin for 72 h at 4
 
 
 
C. They were then dehy-
drated through three changes of 70, 80, 90, and 95% (vol/vol)
ethanol, two changes of absolute ethanol and two changes of pure
chloroform each 12 h. The samples were then embedded in paraf-
fin and cut into sections. The sections (5 
 
 
 
m) were then mounted
on glass slides and spread by warming at 60
 
 
 
C for 30 min. The tis-
sue sections were then deparaffined with xylene and ethanol,
treated with 0.3% (vol/vol) hydrogen peroxide in methanol to in-
activate endogenous peroxidase activity, and finally incubated in
PBS containing 3% (wt/vol) BSA (Sigma-Aldrich) at room tem-
perature for 1 h to block nonspecific staining. The slides were
then incubated with rabbit polyclonal anti-HDC (1:750; Euro-
Figure 2. Effects of anti-VEGF
antibody on angiogenesis and
granulation tissue formation. A
cotton thread (1 cm, 7 mg) was
implanted subcutaneously in the
dorsum of each mouse. Goat
anti-VEGF IgG (1  g) or con-
trol goat IgG (1  g) dissolved in
100  l sterile PBS was subcuta-
neously injected at the site of
cotton thread implantation just
after the implantation and then
once a day on consecutive days.
The mice were killed 5 and 7 d
after cotton thread implantation.
(A) The vascular network forma-
tion around the cotton thread (a)
and the subcutaneous tissue be-
neath the cotton thread (b). (B)
The granulation tissue weight. (C)
Hemoglobin levels in the granula-
tion tissue. Values are the means
from five mice with SEM shown
by vertical bars. **P    0.01;
***P   0.001 compared with val-
ues at 5 d in control group.
###P   0.001 compared with val-
ues in control goat IgG treated
group at corresponding days. 
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diagnostica) in 3% (wt/vol) BSA-PBS at 4
 
 
 
C for 1 h. After being
washed with PBS, they were incubated with biotinylated anti-
rabbit IgG (1:2,000; Vector Laboratories) in 3% (wt/vol) BSA-
PBS at 4
 
 
 
C for 1 h and then with the avidin-biotin peroxidase
complex (1:500; Vector Laboratories) in 3% (wt/vol) BSA-PBS at
room temperature for 30 min. The reaction product was detected
with 50 mM Tris-HCl buffer (pH 7.4) containing 0.05% (wt/vol)
3,3
 
 
 
-diaminobenzidine tetrahydrochloride (Dojin Chemical Lab-
oratories), 0.04% (wt/vol) nickel chloride, and 0.033% (vol/vol)
hydrogen peroxide and HDC-expressing cells were observed with
a light microscope (original magnification: 
 
 
 
400).
 
Immunohistochemical Observation for CD31 Expression.
 
After
dissection, the granulation tissue together with the cotton thread
was fixed, dehydrated, and embedded in paraffin as described
above. The sections (5 
 
 
 
m) were then mounted on glass slides
and spread by warming at 60
 
 
 
C for 30 min. The tissue sections
were then deparaffined with xylene and ethanol, treated with
0.3% (vol/vol) hydrogen peroxide in methanol to inactivate en-
dogenous peroxidase activity, and incubated in PBS containing
1.5% (wt/vol) blocking serum (Santa Cruz Biotechnology, Inc.)
at room temperature for 1 h to block nonspecific staining. The
slides were then incubated with goat polyclonal anti-CD31 (2
 
 
 
g/ml; Santa Cruz Biotechnology, Inc.) in PBS containing 1.5%
(wt/vol) blocking serum at room temperature for 1 h. After be-
ing washed with PBS, they were incubated with biotinylated
anti–goat IgG (1 
 
 
 
g/ml; Santa Cruz Biotechnology, Inc.) in PBS
containing 1.5% (wt/vol) blocking serum at room temperature
for 1 h and then with the avidin-biotin peroxidase complex
(1:500; Santa Cruz Biotechnology, Inc.) in PBS at room temper-
ature for 30 min. The reaction product was detected with freshly
prepared peroxidase substrate mixture containing 1.6 ml distilled
water, five drops 10
 
 
 
 substrate buffer, 1 drop 50 
 
 
 
 3,3
 
 
 
-diami-
nobenzidine tetrahydrochloride chromogen, and 1 drop 50
 
 
 
peroxidase substrate (Santa Cruz Biotechnology, Inc.). CD31-
expressing cells were observed with a light microscope (original
magnification: 
 
 
 
 200).
Figure 3. The defective an-
giogenesis in HDC /  mice. A
cotton thread (1 cm, 7 mg) was
implanted subcutaneously in the
dorsum of each mouse. The
mice were killed 3, 5, and 7 d af-
ter cotton thread implantation.
(A) The vascular network forma-
tion around the cotton thread (a)
and the subcutaneous tissue be-
neath the cotton thread (b). (B)
The granulation tissue weight.
(C) Hemoglobin levels in the
granulation tissue. (D) VEGF
protein levels in the granulation
tissue. VEGF protein levels in
the granulation tissue were de-
termined by immunoblotting
and analyzed densitometrically.
Representative immunoblots from
one mouse in each group are
shown at the top of D. The
mean VEGF protein level in the
granulation tissue 3 d after cotton
thread implantation in HDC / 
mice is set to 1.0. Values are the
means from five mice with SEM
shown by vertical bars. *P   
0.05;  **P    0.01; and ***P   
0.001 compared with values at
3 d in HDC /  mice. #P   0.05;
##P   0.01; and ###P   0.001
compared with values in HDC / 
mice at corresponding days.977 Ghosh et al.
Statistical Analysis. Statistical significance of the results was
analyzed by Dunnett’s test for multiple comparisons and Stu-
dent’s t test for unpaired observations.
Results
Cotton Thread-induced Granulation Tissue Formation, An-
giogenesis, and VEGF Production. Subcutaneous implanta-
tion of a cotton thread in the dorsum of HDC /  mice
induced gradual increases in the weight and hemoglobin
levels of the granulation tissue from 3 to 7 d after cotton
thread implantation (Fig. 1 A and B). In addition, the vas-
cular network formation of the granulation tissue and sub-
cutaneous tissue beneath the cotton thread also increased
over the same time points (Figs. 2 A and 3 A). The levels of
VEGF protein in the granulation tissue were also increased
(Fig. 1 C). To clarify the role of VEGF in the angiogenesis
and granulation tissue formation, goat anti-VEGF IgG or
control goat IgG was subcutaneously injected at the site of
cotton thread implantation just after the implantation and
once a day on consecutive days. The injection of goat anti-
VEGF IgG, but not control goat IgG, suppressed the vas-
cular network formation, as well as the increases in hemo-
globin levels and granulation tissue weight 5–7 d after cotton
thread implantation (Fig. 2). These findings suggest that the
cotton thread-induced angiogenesis is highly dependent on
VEGF and that the inhibition of angiogenesis results in the
inhibition of granulation tissue formation.
Defective Angiogenesis in HDC /  Mice. To clarify the
role of histamine in angiogenesis, we implanted a cotton
thread in the dorsum of HDC /  mice. Vascular network
formation in the granulation tissue and the subcutaneous
tissue beneath the cotton thread in HDC /  mice 3 and 5 d
after cotton thread implantation was notably less than
those in HDC /  mice (Fig. 3 A). In addition, the granula-
tion tissue formation (Fig. 3 B), as well as the levels of he-
moglobin (Fig. 3 C) and VEGF protein in the granulation
tissue (Fig. 3 D) of HDC /  mice were significantly less
than those in HDC /  mice 3 and 5 d after cotton thread
implantation. Concentrations of VEGF proteins in the su-
pernatant of the homogenate of the cotton thread induced-
granulation tissue determined by ELISA also revealed that
the levels of VEGF proteins in the granulation tissue 3 to
7 d after cotton thread implantation were lower in HDC / 
mice than in HDC /  mice (Table I). In addition, immu-
nohistochemical analysis of the granulation tissue dissected
5 d after the cotton thread implantation using an antibody
to CD31, a marker for endothelial cells, indicated that the
neovascular density in the granulation tissue in HDC / 
mice was obviously less than that in HDC /  mice (Fig. 4).
These findings indicate that histamine plays an important
role in the induction of VEGF and angiogenesis during the
early stage of cotton thread-induced granulation tissue.
Table I. VEGF Protein Levels in the Supernatant of the 
Homogenate of the Cotton Thread-induced Granulation Tissue
Mice Days after implantation VEGF protein levelsa
HDC /  3 0.27   0.02
5 0.37   0.03b
7 0.42   0.02c
HDC /  3 0.17   0.02d
5 0.19   0.02e
7 0.24   0.03a, e
aVEGF protein levels are expressed as pg VEGF per µg total protein.
Data represent mean   SEM from four mice. 
bP   0.05.
cP   0.01 compared with values in corresponding 3 d group.
dP   0.05.
eP   0.01 compared with values in HDC /  mice at corresponding days.
Figure 4. Immunohistochemical observation for CD31 expression in
the granulation tissue in mice. A cotton thread (1 cm, 7 mg) was im-
planted subcutaneously in the dorsum of each mouse. The mice were
killed 5 d after cotton thread implantation. The sections of the granula-
tion tissue were immunostained using an antibody to CD31, a marker for
endothelial cells. CD31 expression in the granulation tissue in HDC / 
mice (A) and in HDC /  mice (B) was observed with a light microscope
(original magnification:  200). Representative micrographs are shown
from three samples.978 Defective Angiogenesis in HDC-deficient Mice
Recovery of Defective Angiogenesis in HDC /  Mice by His-
tamine and Dimaprit. Subcutaneous injection of hista-
mine (0.1 and 1  g) or the H2 receptor agonist dimaprit
(0.01, 0.1, and 1  g) at the site of implantation just after
the implantation and then once a day on consecutive days
significantly enhanced angiogenesis in the granulation tis-
sue as well as the granulation tissue formation itself com-
pared with those in mice treated with saline (Fig. 5 A–C).
The VEGF level in the granulation tissue was also in-
creased by the injection of histamine or dimaprit in a dose-
dependent manner (Fig. 5 D). In addition, topical injec-
tions of the H2 receptor antagonist cimetidine inhibited
the histamine-induced angiogenesis in the granulation tis-
sue and subcutaneous tissue beneath the cotton thread
(Fig. 5 E). In contrast, the H1 receptor antagonist pyril-
amine maleate and the H3 receptor antagonist thiopera-
mide had no effect. Cimetidine also inhibited the hista-
mine-induced increases in granulation tissue weight, and
levels of hemoglobin and VEGF in the granulation tissue
(data not shown). These findings indicate that histamine
augments VEGF production via H2 receptors.
Involvement of Histamine Derived from Nonmast Cells in An-
giogenesis. To clarify whether the histamine responsible
for angiogenesis was derived from mast cells, we compared
Figure 5. Effects of histamine
and dimaprit on angiogenesis in
HDC /  mice. A cotton thread
(1 cm, 7 mg) was implanted sub-
cutaneously in the dorsum of
each mouse. Histamine (0, 0.1,
and 1  g), pyrilamine maleate
(3.61  g), cimetidine (2.27  g),
thioperamide (2.63  g), or di-
maprit (0.01, 0.1, and 1  g) dis-
solved in 100  l sterile saline
were injected subcutaneously at
the site of cotton thread implan-
tation just after the implantation
and then once a day on consecu-
tive days. The mice were killed
5 d after cotton thread implanta-
tion. (A and E) The vascular net-
work formation around the cot-
ton thread (a) and the
subcutaneous tissue beneath the
cotton thread (b). (B) The gran-
ulation tissue weight. (C) He-
moglobin levels in the granula-
tion tissue. (D) VEGF protein
levels in the granulation tissue.
VEGF protein levels in the gran-
ulation tissue were determined
by immunoblotting and analyzed
densitometrically. Representa-
tive immunoblots from two
mice in each group are shown at
the top of D. The mean VEGF
protein level in the granulation
tissue in control mice is set to
1.0. Values are the means from
five mice with SEM shown by
vertical bars. **P   0.01; ***P  
0.001 compared with values in
control group.979 Ghosh et al.
the cotton thread-induced granulation tissue formation and
angiogenesis in mast cell–deficient mice (WBB6F1-W/
WV) with those in wild-type mice (WBB6F1
 / ). We
found that there was no significant difference in the granu-
lation tissue formation, angiogenesis and VEGF levels in
the granulation tissue between the two groups (Fig. 6). In
HDC /  mice, the implantation of a cotton thread in-
creased the HDC activity in the tissue surrounding the im-
planted cotton thread including the skin, cutaneous muscle
layer, subcutaneous tissues and the granulation tissue, from
1 to 5 d after implantation (Fig. 7 A). In WBB6F1-W/WV
mice, although the HDC activity in the tissue was very
low due to the mast cell deficiency, the cotton thread im-
plantation induced a marked increase in HDC activity in
the tissue to a similar extent as that in WBB6F1- /  mice
(Fig. 7 B). In addition, histochemical analysis of the granu-
lation tissue dissected 5 d after the cotton thread implanta-
tion indicated the absence of mast cells in the tissue (data
not shown). However, the HDC-producing cells were
shown to be infiltrating macrophages (Fig. 7 C). These
findings indicate that HDC expression is induced in the
nonmast cell, macrophages.
Discussion
Histamine plays a variety of roles as an autacoid which
regulates allergic inflammatory reactions (18, 28), differen-
tiation of leukocytes precursors (29), neutrophil infiltration
into the inflammatory sites (17), and gastric acid secretion
(30). It also acts as a neurotransmitter in the central nervous
system (31). In this study, we demonstrated a significant
role of histamine in angiogenesis, i.e., histamine enhances
angiogenesis in the inflammatory granulation tissue via the
induction of VEGF production.
Subcutaneous implantation of a cotton thread induced
rapid formation of granulation tissue together with angio-
genesis (Figs. 1 and 3). The angiogenesis was highly de-
pendent on VEGF production, as it was strongly inhibited
by goat anti-VEGF IgG (Fig. 2). In addition, we also dem-
onstrated that a reduction in the granulation tissue forma-
tion was accompanied by the inhibition of angiogenesis
(Fig. 1). Thus, the mechanism of angiogenesis in the pro-
liferative inflammatory tissue can be studied in vivo by us-
ing the mouse model of inflammation induced by cotton
thread implantation. Using HDC /  mice, we found that
the development of angiogenesis especially in the early
phase (3–5 d after cotton thread implantation) depends on
endogenous histamine (Figs. 3 and 4). The possibility that
the functioning of hemangioblasts and endothelial cells
were defective due to the destruction of the HDC gene
was ruled out because the injection of histamine or di-
maprit rescued the defective angiogenesis in HDC / 
mice (Fig. 5).
The production of VEGF in HDC /  mice was signifi-
cantly less than HDC /  mice, and the injection of di-
maprit or histamine increased the VEGF levels in the gran-
ulation tissue (Fig. 5 D). In addition, topical injection of
cimetidine inhibited the histamine-induced angiogenesis in
HDC /  mice (Fig. 5 E). Therefore, we concluded that
endogenous histamine enhances VEGF production via H2
receptors. This conclusion corresponds with our previous
in vitro findings that exogenous histamine induces VEGF
production by macrophages, endothelial cells, and fibro-
Figure 6. Comparison of granulation tissue formation between
WBB6F1 /  and WBB6F1-W/WV mice. A cotton thread (1 cm, 7 mg)
was implanted subcutaneously in the dorsum of each mouse. The mice
were killed 5 d after the cotton thread implantation. (A) The vascular net-
work formation around the cotton thread (a) and the subcutaneous tissue
beneath the cotton thread (b). (B) The granulation tissue weight and he-
moglobin levels in the granulation tissue. (C) VEGF protein levels in the
granulation tissue. VEGF protein levels in the granulation tissue were de-
termined by immunoblotting and analyzed densitometrically. Represen-
tative immunoblots from two mice in each group are shown at the top of
C. The mean VEGF protein level in the granulation tissue of WBB6F1
 / 
mice is set to 1.0. Values are the means from five mice with SEM shown
by vertical bars. 980 Defective Angiogenesis in HDC-deficient Mice
blasts present in the granulation tissue via the H2 receptor-
cAMP-protein kinase A pathway (23).
Although it is known that there is increased histamine
production in rapidly growing tissues (16, 17), the hista-
mine-producing cells have not yet been identified. It has
been reported that the number of mast cells in the rapidly
growing tissues increases (32) and that mast cell–derived
histamine is angiogenic (33). However, we found that
HDC activity in the tissue surrounding the implanted cot-
ton thread including the skin, cutaneous muscle layer,
subcutaneous tissues, and the granulation tissue increased
even in WBB6F1-W/WV mice (Fig. 7 A and B). In addi-
tion, histochemical analysis of the granulation tissue dis-
sected 5 d after the cotton thread implantation indicated
the absence of mast cells in the granulation tissue (data not
shown). In contrast, HDC-producing cells in the granula-
tion tissue were identified as infiltrating macrophages (Fig.
7 C). Histamine production by nonmast cells was ob-
served in mouse skin treated with PMA (34), in various
tissues such as liver and lung in IL-1–treated mice (35),
and in the infiltrating leukocytes in allergic inflammation
in rats (36). Our findings did not exclude the possibility
that mast cells in the granulation tissue and the surround-
ing tissues release histamine.
Because the cotton thread implantation induced an ap-
parent angiogenesis in WBB6F1-W/WV mice as well as in
WBB6F1
 /  mice, we concluded that histamine from infil-
trating macrophages play a significant role in angiogenesis
of the granulation tissue. It is reported that cimetidine, an
H2 antagonist, delays wound healing especially in peptic ul-
cer (37, 38), but its mechanism of action has not been clar-
ified. We found that cimetidine reduces VEGF production
in the carrageenin-induced inflammation model in rats
(23). In the cotton thread–induced inflammation model in
mice, treatment with cimetidine showed partial but signifi-
cant inhibition of angiogenesis and VEGF production (data
not shown). Therefore, we hypothesize that cimetidine
delays wound healing by inhibiting histamine-mediated
VEGF production and angiogenesis. Our findings also sug-
gest that H2 receptor antagonists would be useful for sup-
pressing the angiogenesis-dependent formation of inflam-
matory granulation tissue, and conversely, that H2 receptor
agonists may enhance angiogenesis in wound healing and
several ischemic diseases. In addition, because cimetidine
inhibits tumor growth in vivo (39, 40), there is a possibility
that the growth of some tumors may also be regulated by
histamine-mediated angiogenesis.
These findings demonstrate that the defective angiogen-
esis in the inflammatory granulation tissue is induced in
HDC /  mice but not in mast cell–deficient mice, and his-
tamine derived from nonmast cells plays a significant role in
the angiogenesis of the inflammatory granulation tissue.
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